Antibody engineering of a cytotoxic monoclonal antibody 84 against human embryonic stem cells: Investigating the effects of multivalency on cytotoxicity
Engineered cytotoxic scFv fragments against hESC with a valency from one to four were constructed. We hypothesized that higher cytotoxicity would be observed for fragments with increased valency. Trimeric and tetrameric engineered fragments were more cytotoxic to undifferentiated hESC. Engineered fragments showed improved tissue penetration into cell clusters over parental IgM. Implications for antibody-mediated removal of undifferentiated hESC during stem cell therapy.